Staff Publications

Staff Publications

  • external user (warningwarning)
  • Log in as
  • language uk
  • About

    'Staff publications' is the digital repository of Wageningen University & Research

    'Staff publications' contains references to publications authored by Wageningen University staff from 1976 onward.

    Publications authored by the staff of the Research Institutes are available from 1995 onwards.

    Full text documents are added when available. The database is updated daily and currently holds about 240,000 items, of which 72,000 in open access.

    We have a manual that explains all the features 

Record number 418336
Title Rationales for including adjuvants in vaccines
Author(s) Schijns, V.E.J.C.; Lavelle, E.C.
Source In: Novel Immunologic Adjuvants / Rappuoli, R., De Gregorio, E., - p. 6 - 14.
Department(s) Cell Biology and Immunology
Publication type Peer reviewed book chapter
Publication year 2011
Abstract The majority of vaccine antigens in the industry pipeline are relatively poor inducers of adaptive immunity unless effective adjuvants are coadministered. Adjuvants based on aluminium salts have been the only approved and available adjuvant for almost a century. However, although alum effectively promotes humoral immunity, it is not effective for diseases where cell-mediated immunity is required for protection. Moreover, other particulate adjuvants are superior to alum in promoting antibody responses to pandemic influenza antigens. There has been considerable progress in the discovery of novel antigens, which is facilitating vaccine development for currently intractable and new diseases, including therapeutic indications. Hence, especially when cell-mediated immune responses are required, these antigens demand a new generation of adjuvant, which can drive and specifically direct the desired immune responses. In parallel, increased understanding of immunology and, particularly, innate immune sensing is informing vaccine adjuvant research and driving the development of novel and specifically targeted vaccine strategies. In this concise chapter we address the importance of adjuvants in the important field of modern vaccine development
There are no comments yet. You can post the first one!
Post a comment
Please log in to use this service. Login as Wageningen University & Research user or guest user in upper right hand corner of this page.